Dr. Fredi Aviv has 34 years of experience of experience specializing in oncohematology at Sourasky Medical Center.
Dr. Dror Levin leads the children's hematology oncology department at Sourasky Medical Center, specializing in pediatric blood disorders.
Dr. Kirshner actively contributes to advancing hematology through clinical trials, including a phase III trial for castrate-resistant prostate cancer.
A leading oncologist and professor from the Medical University of Vienna, focusing on personalized systemic cancer therapy. He now sees patients at Wiener Privatklinik.
Leading oncologist Professor Drach has directed a prestigious myeloproliferative neoplasms clinic for years. He offers both private practice and clinical leadership at Vienna's Confraternitaet Private Hospital.
Specializes in hematologic conditions including thrombocytopenia at Medical Park Antalya Hospital Complex.
Dr. Eckhart Weidmann heads the Hematology sector at Nordwest Clinic with over 36 years of experience of practice. He specializes in blood disorder treatment.
Dr. Gal Goldstein is a Forbes-listed pediatric hemato-oncology specialist at Hadassah Medical Center, recognized as one of Israel's best doctors.
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.
He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.
Leading expert in Chronic Lymphocytic Leukemia (CLL) – Professor Bosch has pioneered new treatments and technologies for hematological diseases.
Prof. Dr. Serdar Bedii Omay has published 65+ scientific articles on hematology and bone marrow transplantation, trained at Japan's Mie Medical Faculty.
Prof. Baytan specializes in pediatric hematology, focusing on childhood bleeding disorders and cancers at Emsey Hospital.